See the DrugPatentWatch profile for aspirin

Based on the information available, there is no definitive evidence to suggest that taking Vascepa (icosapent ethyl) in combination with aspirin increases the risk of bleeding. However, both Vascepa and aspirin are known to have antiplatelet effects, which can increase the risk of bleeding [1].

Vascepa is a prescription medication approved by the FDA for use along with a healthy diet to reduce the risk of heart attack and stroke in adults with triglyceride levels of 150 mg/dL or higher. It works by reducing the production of triglycerides in the body [2].

Aspirin, on the other hand, is a common over-the-counter medication used for its anti-inflammatory and antiplatelet effects. It works by preventing the formation of blood clots, which can help prevent heart attacks and strokes [3].

While both medications can increase the risk of bleeding, there is no specific mention of an increased risk when taken together in the prescribing information for Vascepa or in clinical studies [1][2]. However, it is important to note that individual responses to medications can vary, and patients should speak with their healthcare provider before taking any new medications or supplements.

In summary, while there is no definitive evidence to suggest that taking Vascepa and aspirin together increases the risk of bleeding, both medications can affect blood clotting and increase the risk of bleeding on their own. Patients should speak with their healthcare provider before taking any new medications or supplements.

Sources:

1. <https://www.ncbi.nlm.nih.gov/books/NBK557822/>
2. <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/vascepa-icosapent-ethyl-capsules-information>
3. <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/single-ingredient-non-aspirin-nonprescription-naloxone-hydrochloride-products-information>
4. <https://www.drugpatentwatch.com/drugs/vascepa>